ProQR Therapeutics NV logo

ProQR Therapeutics NV

NAS:PRQR (Netherlands)  
$ 2.48 -0.09 (-3.52%) 11:08 PM EST
At Loss
P/B:
4.41
Market Cap:
$ 201.68M
Enterprise V:
$ 100.34M
Volume:
215.16K
Avg Vol (2M):
376.97K
Also Trade In:
Volume:
215.16K
At Loss
Avg Vol (2M):
376.97K

Business Description

Description
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.
Name Current Vs Industry Vs History
Cash-To-Debt 6.03
Equity-to-Asset 0.3
Debt-to-Equity 0.48
Debt-to-EBITDA -0.83
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -2.73
Distress
Grey
Safe
Beneish M-Score -4.99
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 75.2
9-Day RSI 71.65
14-Day RSI 66.79
6-1 Month Momentum % 26.62
12-1 Month Momentum % -40

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.54
Quick Ratio 3.54
Cash Ratio 3.48

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -17.5
Shareholder Yield % 10.3

Financials (Next Earnings Date:2024-05-16 Est.)

PRQR's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PRQR

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

ProQR Therapeutics NV Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 7.05
EPS (TTM) ($) -0.377
Beta -0.12
Volatility % 65.44
14-Day RSI 66.79
14-Day ATR ($) 0.18822
20-Day SMA ($) 2.07995
12-1 Month Momentum % -40
52-Week Range ($) 1.11 - 3.85
Shares Outstanding (Mil) 81.35

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ProQR Therapeutics NV Filings

Filing Date Document Date Form
No Filing Data

ProQR Therapeutics NV Stock Events

Financials Calendars
Event Date Price($)
No Event Data

ProQR Therapeutics NV Frequently Asked Questions

What is ProQR Therapeutics NV(PRQR)'s stock price today?
The current price of PRQR is $2.48. The 52 week high of PRQR is $3.85 and 52 week low is $1.11.
When is next earnings date of ProQR Therapeutics NV(PRQR)?
The next earnings date of ProQR Therapeutics NV(PRQR) is 2024-05-16 Est..
Does ProQR Therapeutics NV(PRQR) pay dividends? If so, how much?
ProQR Therapeutics NV(PRQR) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1